Columns

How I kept going after a discouraging diagnosis of MS

Let me introduce myself: I’m Mike, and if you don’t mind, I’d like to share my story. I was diagnosed with multiple sclerosis (MS) in August 2022. Since then, a lot has changed, including the loss of a 20-year career, worsening mobility problems, and the start of…

MS news notes: Vumerity, herpes virus, caregivers

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at some of what’s been happening: A good report for Vumerity Final results are in from the EVOLVE-MS-1 clinical trial for patients with…

MS news notes: COVID-19, MS blood tests

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at some of what’s been happening. MS relapses and COVID-19 Since COVID-19 became a concern over three years ago, I’ve read many comments…

What I’m thankful for this Thanksgiving

It wasn’t a good morning. I was dragging my cement-pillar legs around the kitchen and grew frustrated as I lurched from the refrigerator to the counter to feed the cat and the dog. I’d propped my two canes against the counter, but they’d slid to the floor — not once,…

MS news notes: ATA188, biomarkers for MS progression

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: ATA188 fails a big test ATA188 is an experimental cell therapy developed by Atara Biotherapeutics aimed at easing MS…

My multiple sclerosis has made me more suspicious

As I’ve mentioned a time or two, my wife and I have three boys. Although they’re all under the age of 12, they’ve started to talk like the budding teenagers they are. As they mingle with peers more than their parents, their vocabulary in particular becomes less like ours every…

MS news notes: Stem cell transplant, artificial intelligence

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Lemtrada or stem cell transplant? While the U.S. Food and Drug Administration has not yet approved stem cell transplants…

My bladder is doing much better these days, but why?

I slept through the night last night. Recently, I’ve managed to do that on most nights. No 4 a.m. bathroom trips for me! That’s a big deal. There was a time when I’d get up two or even three times during the night for a bladder run. Sleeping seven or…

MS news notes: Dalfampridine, Neural Sleeve, vitamin D

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Dalfampridine side effects The side effects that might occur if you use dalfampridine (sold under the brand name Ampyra)…

MS news notes: EBV, stopping a DMT, 3 treatment reports

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. This week, the stories cover research presented at the joint meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the…

MS news notes: Silent progression, ignoring treatments

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: ‘Silent’ MS progression Readers of the MS News Today website and Facebook page sometimes wonder why their MS…